Immutep Management
Management criteria checks 3/4
Immutep's CEO is Marc Voigt, appointed in Nov 2012, has a tenure of 10.33 years. total yearly compensation is A$1.06M, comprised of 44.8% salary and 55.2% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth $2.15M. The average tenure of the management team and the board of directors is 6.9 years and 2.5 years respectively.
Key information
Marc Voigt
Chief executive officer
AU$1.1m
Total compensation
CEO salary percentage | 44.8% |
CEO tenure | 12yrs |
CEO ownership | 0.8% |
Management average tenure | 6.9yrs |
Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | AU$1m | AU$477k | -AU$43m |
Mar 31 2024 | n/a | n/a | -AU$42m |
Dec 31 2023 | n/a | n/a | -AU$41m |
Sep 30 2023 | n/a | n/a | -AU$40m |
Jun 30 2023 | AU$1m | AU$440k | -AU$40m |
Mar 31 2023 | n/a | n/a | -AU$38m |
Dec 31 2022 | n/a | n/a | -AU$37m |
Sep 30 2022 | n/a | n/a | -AU$34m |
Jun 30 2022 | AU$943k | AU$428k | -AU$32m |
Mar 31 2022 | n/a | n/a | -AU$29m |
Dec 31 2021 | n/a | n/a | -AU$26m |
Sep 30 2021 | n/a | n/a | -AU$28m |
Jun 30 2021 | AU$995k | AU$409k | -AU$30m |
Mar 31 2021 | n/a | n/a | -AU$29m |
Dec 31 2020 | n/a | n/a | -AU$27m |
Sep 30 2020 | n/a | n/a | -AU$20m |
Jun 30 2020 | AU$926k | AU$411k | -AU$13m |
Mar 31 2020 | n/a | n/a | -AU$15m |
Dec 31 2019 | n/a | n/a | -AU$16m |
Sep 30 2019 | n/a | n/a | -AU$17m |
Jun 30 2019 | AU$837k | AU$399k | -AU$18m |
Mar 31 2019 | n/a | n/a | -AU$18m |
Dec 31 2018 | n/a | n/a | -AU$17m |
Sep 30 2018 | n/a | n/a | -AU$15m |
Jun 30 2018 | AU$1m | AU$401k | -AU$13m |
Compensation vs Market: Marc's total compensation ($USD699.70K) is below average for companies of similar size in the US market ($USD1.47M).
Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.
CEO
Marc Voigt (51 yo)
12yrs
Tenure
AU$1,064,669
Compensation
Mr. Marc Voigt has been the Chief Executive Officer of Immutep Limited (formerly, Prima BioMed Ltd) since July 9, 2014. Mr. Voigt has been an Executive Director of Immutep Limited since July 9, 2014. He se...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD | 12yrs | AU$1.06m | 0.78% $ 2.1m | |
COO, General Counsel & Joint Company Secretary | 12.1yrs | AU$565.23k | 0.18% $ 508.3k | |
Chief Scientific Officer & Executive Director | 9.9yrs | AU$864.44k | 0.61% $ 1.7m | |
Chief Medical Officer | 1.5yrs | AU$955.82k | no data | |
Senior Vice President of Regulatory & Strategy | 1.1yrs | no data | no data | |
Joint Company Secretary | 3.8yrs | no data | no data |
6.9yrs
Average Tenure
51yo
Average Age
Experienced Management: PRRU.F's management team is seasoned and experienced (6.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD | 10.3yrs | AU$1.06m | 0.78% $ 2.1m | |
Chief Scientific Officer & Executive Director | 2.2yrs | AU$864.44k | 0.61% $ 1.7m | |
Independent Non-Executive Chairman | 11.5yrs | AU$163.52k | 0.077% $ 212.2k | |
Independent Non-Executive Deputy Chairman | 10.8yrs | AU$138.71k | 0.25% $ 698.2k | |
Chairman of Clinical Advisory Board | 7.4yrs | no data | no data | |
Member of Clinical Advisory Board | 2.5yrs | no data | no data | |
Member of Clinical Advisory Board | 2.5yrs | no data | no data | |
Non-Executive Director | 1.6yrs | AU$144.76k | no data | |
Member of Clinical Advisory Board | 7.4yrs | no data | no data | |
Member of Clinical Advisory Board | 2.5yrs | no data | no data | |
Member of Clinical Advisory Board | 2.5yrs | no data | no data |
2.5yrs
Average Tenure
61.5yo
Average Age
Experienced Board: PRRU.F's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.